Correction: RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors(Clin Cancer Res. (2016)22:6 (1499-509) DOI: 10.1158/1078-0432.CCR-15-1125)

  • Sherene Loi
  • , Sathana Dushyanthen
  • , Paul A. Beavis
  • , Roberto Salgado
  • , Carsten Denkert
  • , Peter Savas
  • , Susan Combs
  • , David L. Rimm
  • , Jennifer M. Giltnane
  • , Monica V. Estrada
  • , Violeta Sanchez
  • , Melinda E. Sanders
  • , Rebecca S. Cook
  • , Mark A. Pilkinton
  • , Simon A. Mallal
  • , Kai Wang
  • , Vincent A. Miller
  • , Phil J. Stephens
  • , Roman Yelensky
  • , Franco D. Doimi
    • Henry Gomez, Sergey V. Ryzhov, Phillip K. Darcy, Carlos L. Arteaga, Justin M. Balko

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction: RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors(Clin Cancer Res. (2016)22:6 (1499-509) DOI: 10.1158/1078-0432.CCR-15-1125)'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases